ORTX News and Press, Orchard Therapeutics plc From 07/26/21

Orchard Therapeutics plc (NASDAQ:ORTX) traded today at a new 52-week low of $3.00. So far today approximately 149,000 shares have been exchanged, as compared to an average 30-day volume of 619,000 shares. Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integr...

Shares of Orchard Therapeutics plc (NASDAQ:ORTX) traded today at $3.20, breaking its 52-week low. Approximately 149,000 shares have changed hands today, as compared to an average 30-day volume of 610,000 shares. Potential upside of 22.8% exists for Orchard Therapeutics plc, based on a cu...

Shares of Orchard Therapeutics plc (NASDAQ:ORTX) traded today at $3.23, breaking its 52-week low. This new low was reached on below average trading volume as 149,000 shares traded hands, while the average 30-day volume is approximately 608,000 shares. Orchard Therapeutics plc (NASDAQ:ORT...

Shares of Orchard Therapeutics plc (NASDAQ:ORTX) traded today at $3.28, breaking its 52-week low. This new low was reached on below average trading volume as 149,000 shares traded hands, while the average 30-day volume is approximately 596,000 shares. Orchard Therapeutics plc has overhea...

Shares of Orchard Therapeutics plc (NASDAQ:ORTX) traded at a new 52-week low today of $3.59. So far today approximately 149,000 shares have been exchanged, as compared to an average 30-day volume of 581,000 shares. Potential upside of 53.4% exists for Orchard Therapeutics plc, based on a...

Shares of Orchard Therapeutics plc (NASDAQ:ORTX) traded at a new 52-week low today of $3.62. So far today approximately 149,000 shares have been exchanged, as compared to an average 30-day volume of 563,000 shares. Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fu...

naphtalina/iStock via Getty Images A few collaboration deals in the drug-development space are sparking big gains in Thursday's pre-market action. Spero Therapeutics (SPRO) posted a notable advance, thanks to an investment from drug-making giant Pfizer (PFE). Orchard Therapeutics (ORTX) climb...

Alterity Therapeutics Limited (ATHE) +57% on a new patent by USPTO.Birks Group (BGI) +49% on re-opening of its retail stores across Canada.Wunong Net Technology Company (WNW) +46%.Spero Therapeutics (SPRO) +23% on $40M equity investment from Pfizer.Bridgeline Digital (BLIN) +21...

Orchard Therapeutics (ORTX) and Pharming Group (PHAR) announce a strategic collaboration to research, develop, manufacture and commercialize OTL-105, an investigational ex vivo autologous hematopoietic stem cell ((HSC)) gene therapy for the treatment of hereditary angioedema ((HAE)), a rare d...

Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications Reinforces Pharming’s commitment to the HAE community and utilizes its relevant clinical expertise and global commercialization infrastructure ...